ELECTROPEG SOLUTION 6.7 G / 277 G
SODIUM BICARBONATE : 6.7 G / 277 G POTASSIUM CHLORIDE : 3 G / 277 G SODIUM SULFATE : 22.7 G / 277 G SODIUM CHLORIDE : 5.8 G / 277 G POLYETHYLENE GLYCOL 3350 : 238.8 G / 277 G · DIN 02230825 · TECHNILAB PHARMA INC.
Health Canada status: CANCELLED POST MARKET
What is ELECTROPEG SOLUTION?
ELECTROPEG SOLUTION 6.7 G / 277 G contains SODIUM BICARBONATE : 6.7 G / 277 G POTASSIUM CHLORIDE : 3 G / 277 G SODIUM SULFATE : 22.7 G / 277 G SODIUM CHLORIDE : 5.8 G / 277 G POLYETHYLENE GLYCOL 3350 : 238.8 G / 277 G. It is listed in the Health Canada Drug Product Database under DIN 02230825, held by TECHNILAB PHARMA INC., supplied as POWDER for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 27-Sep-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02230825 |
|---|---|
| Brand name | ELECTROPEG SOLUTION |
| Generic / active ingredient | SODIUM BICARBONATE : 6.7 G / 277 G POTASSIUM CHLORIDE : 3 G / 277 G SODIUM SULFATE : 22.7 G / 277 G SODIUM CHLORIDE : 5.8 G / 277 G POLYETHYLENE GLYCOL 3350 : 238.8 G / 277 G |
| Manufacturer | TECHNILAB PHARMA INC. |
| Strength | 6.7 G / 277 G |
| Dosage form | POWDER |
| Route of administration | ORAL |
| Schedule | Ethical |
| ATC code | A06AD10 MINERAL SALTS IN COMBINATION |
| AHFS class | 28:08.04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 27-Sep-1999 |
| Original market date | 1999-01-24 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AD10 MINERAL SALTS IN COMBINATION. 1 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PEGLYTE POWDER | 5.85 G | POWDER FOR SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 00777838 |
| CEO-TWO BOWEL EVACUANT SUPPOSITORIES | 627 MG | SUPPOSITORY | BEUTLICH L.P. | CANCELLED POST MARKET | DIN 02090074 |
| EAU PURGATIVE RIGA | 2.4 G / 30 ML | LIQUID | GLENDALE AGENCIES | CANCELLED POST MARKET | DIN 00421359 |
| GOLYTELY GI LAVAGE SOLUTION | 22.74 G / 4 L | POWDER FOR SOLUTION | BRAINTREE LABORATORIES INC. | CANCELLED POST MARKET | DIN 00652512 |
| KLEAN-PREP | 740 MG | POWDER FOR SOLUTION | RICHMOND PHARMACEUTICALS INC. | CANCELLED POST MARKET | DIN 00741175 |
| LYTEPREP | 2.97 G | POWDER | THERAPEX DIVISION DE E-Z-EM CANADA INC | CANCELLED POST MARKET | DIN 02239569 |
| LYTEPREP | 25 MMOL | POWDER FOR SOLUTION | THERAPEX DIVISION DE E-Z-EM CANADA INC | CANCELLED POST MARKET | DIN 00695335 |
| OCL SOLUTION | 1.68 MG | SOLUTION | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 00709298 |
| PEGLYTE SOLUTION | 1.46 G | LIQUID | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 00777846 |
| PMS-PEGLYTE | 3.05 G | POWDER FOR SOLUTION | PHARMASCIENCE INC | APPROVED | DIN 02471590 |
Who else supplies MINERAL SALTS IN COMBINATION worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MINERAL SALTS IN COMBINATION appears in 663 registered pack listings across 2 markets, published on 1 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.